Author

Robert Miday

Observed names: R K Miday, R Miday, R. Miday, R.K. Miday, ROBERT K. MIDAY, Robert K. Miday

Observed institutions: Environmental Protection Agency, Hebrew University of Jerusalem, Procter & Gamble (United States)

OpenAlex ID: A5036095802

The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK

2009 · C. Cooper, M. Steinbuch, et al. · Osteoporosis International · 158

Chlorine Dioxide Water Disinfection: A Praspective Epidemiology Study

1981 · GEORGE E. MICHAEL, ROBERT K. MIDAY, et al. · Archives of Environmental Health An International Journal · 55

Phase II study of MEDI-575, an anti-platelet-derived growth factor-α antibody, in patients with recurrent glioblastoma

2016 · Surasak Phuphanich, Jeffrey Raizer, et al. · Journal of Neuro-Oncology · 22

Postmarketing Surveillance of New Food Ingredients: Design and Implementation of the Program for the Fat Replacer Olestra

2001 · Candice L. Slough, Robert K. Miday, et al. · Regulatory Toxicology and Pharmacology · 14

Toxic shock syndrome: incidence and geographic distribution from a hospital medical records reporting system.

1988 · R K Miday, E R Wilson · American Journal of Public Health · 6

A Peripheral Vascular Insufficiency Test Using Photocell Plethysmography

1981 · S Samueloff, R Miday, et al. · Journal of Occupational and Environmental Medicine · 6

Most severe neutropenia in individuals with no chronic condition did not result in a specific diagnosis

2004 · Diana B. Petitti, Richard Contreras, et al. · Journal of Clinical Epidemiology · 4

A six-week randomized controlled trial of olestra or regular snack foods: Comparison of Gastro-intestinal symptoms in a large population

1998 · R.S. Sandler, N.L. Zorich, et al. · Gastroenterology · 3

SAT0249 Safety, pharmacokinetics, pharmacodynamics and inhibition of T-cell dependent antibody response (TDAR) with MEDI4920, a novel, engineered CD40 ligand (CD40L) antagonist: results of a first-time-in-human study

2017 · MG Albulescu, M Gunsior, et al. · Annals of the Rheumatic Diseases · 2

ATCT-07PHASE 2 STUDY OF MEDI-575, AN ANTI-PLATELET-DERIVED GROWTH FACTOR-α ANTIBODY, IN PATIENTS WITH RECURRENT GLIOBLASTOMA

2015 · Surasak Phuphanich, Jeffrey Raizer, et al. · Neuro-Oncology

Gastrointestinal Symptoms Following Olestra Consumption—Reply

1998 · Lawrence J. Cheskin, Nora Zorich, et al. · JAMA

Works count: 11

Citation count: 270

H-index: 6

I10-index: 4